Ofir Wolach

21PUBLICATIONS
74CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursLiquid biopsiesInnate immunityRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jan 22, 2026
Glucose-6-phosphate dehydrogenase deficiency is associated with improved survival in patients with acute myeloid leukemia treated with venetoclax and azacitidine.

Shira Buchrits, Alon Rozental, Noa Korngold

|Oct 31, 2025
Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL.

Daniela R Anderson, Radhika Gangaraju, Wafik George Sedhom

|Mar 28, 2025
Tumor-Associated Lactic Acidosis and Early Death in Patients With Lymphoma.

Bahaa Atamna, Alon Rozental, Mohammad Haj Yahia

|Jan 08, 2025
Interferon-α Inhibits NET Formation in Neutrophils Derived from Patients with Myeloproliferative Neoplasms in a Neutrophil Sub-Population-Specific Manner.

Shirly Partouche, Idan Goldberg, Erez Halperin

|Dec 05, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study.

Ofir Wolach, Itai Levi, Boaz Nachmias

|Jun 21, 2024
Genotype-phenotype correlations in chronic granulomatous disease: insights from a large national cohort.

Baruch Wolach, Ronit Gavrieli, Ofir Wolach

Pageof 4

Frequent Collaborators

5 joint publications

Shai Shimony

4 joint publications

Liat Shargian

4 joint publications

Chezi Ganzel

4 joint publications

Yishai Ofran